Pulmatrix, Inc.
Pulmatrix develops inhaled therapeutic products for migraine and respiratory diseases using its iSPERSE dry powder delivery platform.
424B3Sep 25Latest SEC filing
Aug 13Latest story
August 2026
Pulmatrix develops inhaled therapeutic products for migraine and respiratory diseases using its iSPERSE dry powder delivery platform.